Michel Finet
Inventor
Stats
- 7 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 8 US Applications Filed
- 44 Total Citation Count
- Jan 18, 2011 Most Recent Filing
- Sep 21, 1998 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
SANOFI-AVENTIS | 2
2 1 2 | 2006
2009 2010 2011 |
SANOFI-AVENTIS U.S. LLC | 1
| 2006
|
LABORATOIRES INNOTHERA | 2
| 1998
|
SANOFI | 2
2 | 2006
2009 |
Inventor Addresses
Address | Duration |
---|---|
Budapest, HU | Sep 21, 06 - Dec 06, 11 |
Chatenay Malabry, FR | Nov 09, 99 - Jul 17, 01 |
Le Vesinet, HU | Aug 26, 10 - Dec 25, 12 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 6 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
C07C: | ACYCLIC OR CARBOCYCLIC COMPOUNDS | 2 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
8338411 | 2012 | Compounds | 0 |
8071601 | 2011 | Aminoquinoline derivatives and their use as adenosine A3 ligands | 0 |
2011/0112,092 | 2011 | AMINOQUINOLINE DERIVATIVES AND THEIR USE AS ADENOSINE A3 LIGANDS | 0 |
2011/0009,626 | 2011 | AMINOQUINOLINE DERIVATIVES AND THEIR USE AS ADENOSINE A3 LIGANDS | 0 |
7812031 | 2010 | Pyrimidine derivatives as orexin receptor antagonists | 11 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.